Gennova Biopharmaceuticals CEO Sanjay Singh tells ThePrint their vaccine could be stored at around 2 to 8 degrees Celsius, and the trial is likely to be completed by March.
It’s an abundance that never happened in the history of vaccines. Balancing urgency with research ethics won’t be easy. But so much rides on getting it right.
A vaccine developed by US-based Pfizer and Germany's BioNTech has shown 90% efficacy in trials, but pharma giant says the number may vary with further trials.
The Pfizer trial started less than four months ago, and how long the vaccine will confer protection and how many will benefit are almost complete unknowns for now.
The experimental shot appears more than 90% effective in stopping SARS-CoV-2 infections. If the data hold up, that means that for every 10 cases of Covid-19, nine could be stopped.
India should have secured greater savings by pressing Russia for prices nearer the cap while sustaining high volumes. This would have preserved strategic autonomy and served economic logic.
One such website has drawn particular scrutiny for spreading fake stories that have upset not only the Indian but also foreign defence firms by falsely attributing misinformation.
COMMENTS